X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (32) 32
humans (27) 27
male (21) 21
female (16) 16
aged (15) 15
angiogenesis (13) 13
endocrinology & metabolism (11) 11
inflammation (11) 11
animals (10) 10
cardiac & cardiovascular systems (10) 10
vascular endothelial growth factor (10) 10
expression (9) 9
risk factors (9) 9
diabetes (8) 8
ischemia (8) 8
mice (8) 8
peripheral vascular disease (8) 8
endothelial growth-factor (7) 7
middle aged (7) 7
alzheimer's disease (6) 6
analysis (6) 6
atherosclerosis (6) 6
biomarkers (6) 6
clinical neurology (6) 6
cytokines (6) 6
mice, inbred c57bl (6) 6
retrospective studies (6) 6
type 2 diabetes (6) 6
vascular calcification (6) 6
aged, 80 and over (5) 5
cardiovascular-disease (5) 5
cerebrospinal fluid (5) 5
critical limb ischemia (5) 5
dementia (5) 5
diabetes mellitus (5) 5
diabetes mellitus, type 2 - complications (5) 5
genetic aspects (5) 5
genetic association studies (5) 5
hmgb1 (5) 5
neovascularization, physiologic - drug effects (5) 5
original investigation (5) 5
osteoprotegerin (5) 5
patients (5) 5
polymorphism, single nucleotide (5) 5
research (5) 5
rheumatoid-arthritis (5) 5
tumor necrosis factor-tnf (5) 5
vascular diseases (5) 5
vegf (5) 5
abridged index medicus (4) 4
arteriosclerosis (4) 4
cell biology (4) 4
cells (4) 4
coronary-artery-disease (4) 4
diabetic mice (4) 4
diseases of the circulatory system (4) 4
endothelial progenitor cells (4) 4
gene expression (4) 4
hindlimb - blood supply (4) 4
ischemia - physiopathology (4) 4
monocyte chemoattractant protein-1 (4) 4
neovascularization, physiologic - physiology (4) 4
neurosciences (4) 4
osteoprotegerin - genetics (4) 4
pharmacology & pharmacy (4) 4
proteins (4) 4
risk (4) 4
activation (3) 3
alpha-synuclein (3) 3
alzheimer disease - cerebrospinal fluid (3) 3
amyloid (3) 3
association (3) 3
cardiology and cardiovascular medicine (3) 3
cardiovascular disease (3) 3
case-control studies (3) 3
cells, cultured (3) 3
cilostazol (3) 3
complications and side effects (3) 3
coronary vessels (3) 3
csf biomarkers (3) 3
development and progression (3) 3
diabetics (3) 3
genetic predisposition to disease (3) 3
genetic research (3) 3
genotype (3) 3
health risk assessment (3) 3
heart (3) 3
immunology (3) 3
interleukin 6 (3) 3
intermittent claudication (3) 3
italy (3) 3
medicine, general & internal (3) 3
mild cognitive impairment (3) 3
mobility (3) 3
mortality (3) 3
muscle, skeletal - blood supply (3) 3
neovascularization (3) 3
neurology (3) 3
opg (3) 3
osteoporosis (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2016, Volume 75, Issue Suppl 2, pp. 1090 - 1090
BackgroundSystemic vasculitides represent a heterogeneous group of diseases that share clinical features including respiratory distress, renal dysfunction, and... 
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2017, Volume 76, Issue Suppl 2, p. 1077
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2016, Volume 75, Issue Suppl 2, pp. 926 - 927
BackgroundZeta-chain-associated protein kinase 70 (ZAP-70), a tyrosine kinase constitutively expressed in T cells, can be found in B cells and is used as a... 
Journal Article
Clinical & Experimental Immunology, ISSN 0009-9104, 04/2016, Volume 184, Issue 1, pp. 62 - 72
Summary High‐mobility group box 1 (HMGB1) has been implicated in angiogenesis and rheumatoid arthritis (RA). The aim of this study was to define more clearly... 
high‐mobility group box 1 | rheumatoid arthritis | angiogenesis | vascular endothelial growth factor | Angiogenesis | High-mobility group box 1 | Vascular endothelial growth factor | Rheumatoid arthritis | RHEUMATOID-ARTHRITIS | INTERLEUKIN 17 | DIABETIC MICE | INFLAMMATORY DISEASES | REGENERATION | CHROMOSOMAL-PROTEIN-1 | PROLIFERATION | HMGB1 | IMMUNOLOGY | high-mobility group box 1 | DIFFERENTIATION | Arthritis, Experimental - drug therapy | Arthritis, Experimental - genetics | Tumor Necrosis Factor-alpha - genetics | Interleukin-17 - immunology | Synovial Membrane - immunology | Synovial Membrane - pathology | Male | HMGB1 Protein - immunology | Synovial Membrane - drug effects | Interleukin-1beta - genetics | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Vascular Endothelial Growth Factor A - genetics | HMGB1 Protein - genetics | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Neovascularization, Pathologic - pathology | Arthritis, Experimental - pathology | Collagen Type II - blood | HMGB1 Protein - pharmacology | Vascular Endothelial Growth Factor A - agonists | Tumor Necrosis Factor-alpha - immunology | Neovascularization, Pathologic - prevention & control | Neovascularization, Pathologic - immunology | HMGB1 Protein - antagonists & inhibitors | Severity of Illness Index | Gene Expression | Collagen Type II - immunology | Interleukin-6 - genetics | Interleukin-17 - genetics | Interleukin-1beta - immunology | Vascular Endothelial Growth Factor A - immunology | Arthritis, Experimental - immunology | Peptides - pharmacology | Vascular Endothelial Growth Factor Receptor-1 - pharmacology | Animals | Interleukin-6 - immunology | Antibodies - blood | Neovascularization, Pathologic - genetics | Mice | Mice, Inbred BALB C | Rheumatoid factor | Enzymes | Arthritis | Endothelial growth factors | Collagen | Analysis | Tumor necrosis factor-TNF | Cytokines | Pathogenesis | Original
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2015, Volume 74, Issue Suppl 2, pp. 210 - 211
BackgroundHigh-mobility group box 1 (HMGB1) is a non-histone nuclear protein that is released extracellulary and has been implicated in rheumatoid arthritis... 
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2015, Volume 74, Issue Suppl 2, pp. 294 - 294
BackgroundHigh glucocorticoids doses represent the standard of care in Giant Cell Arteritis (GCA)1.ObjectivesThe aim of the study was to assess the disease... 
Journal Article
DIABETES CARE, ISSN 0149-5992, 10/2019, Volume 42, Issue 10, pp. 1939 - 1945
OBJECTIVE Peripheral artery disease (PAD) is one of the most relevant complications of diabetes. Although several pharmacological and revascularization... 
C-REACTIVE PROTEIN | CRITICAL LIMB ISCHEMIA | STENT IMPLANTATION | ULCERATED FOOT | ANGIOPLASTY | POLYMORPHISMS | RIVAROXABAN | ENDOCRINOLOGY & METABOLISM | PERIPHERAL ARTERY-DISEASE | INFECTION | TNFRSF11B | Complications and side effects | Research | Diabetes | Cytokines | Peripheral vascular diseases | Risk factors
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 08/2017, Volume 16, Issue 1, pp. 99 - 9
Journal Article
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, ISSN 1128-3602, 11/2016, Volume 20, Issue 21, pp. 4574 - 4580
OBJECTIVE: RANKL is a member of the TNF superfamily that stimulates chemokine release, monocyte/macrophage matrix migration and matrix metalloproteinase... 
SYSTEM | BONE-MINERAL DENSITY | VASCULAR CALCIFICATION | History of ischemic stroke | RANKL gene polymorphisms | SERUM OSTEOPROTEGERIN LEVELS | OPG gene polymorphisms | MAJOR SUBTYPES | RANK LIGAND | RECEPTOR ACTIVATOR | CARDIOVASCULAR-DISEASE | CAROTID PLAQUE | PHARMACOLOGY & PHARMACY | KAPPA-B LIGAND
Journal Article